Condition / Treatment neurological

Parkinson’s disease and Deep brain stimulation (DBS)

Deep brain stimulation (DBS) is a surgical therapy used to manage motor symptoms of Parkinson’s disease (PD). Thin electrodes are implanted into specific deep brain targets—most commonly the subthalamic nucleus (STN) or the internal segment of the globus pallidus (GPi)—and connected to a pulse generator in the chest. Electrical stimulation modulates motor circuits that are dysregulated in PD. Robust clinical trials show that DBS can substantially improve tremor, rigidity, and bradykinesia, and reduce medication-induced dyskinesias in appropriately selected individuals. Importantly, DBS manages symptoms; it does not cure PD or halt disease progression. Candidacy and timing hinge on several factors. Candidates typically have idiopathic PD with symptoms that improve with levodopa but are complicated by motor fluctuations, troublesome dyskinesia, or disabling tremor despite optimized medication. Common exclusions include significant dementia, uncontrolled depression or psychosis, and major medical or surgical risks. Decisions weigh age and overall health, pattern of symptoms, responsiveness to medication, lifestyle demands, support systems, and patient goals. Studies suggest that choosing DBS earlier in the course of motor complications can yield better quality-of-life gains than waiting until late disability, though timing remains individualized. Expected benefits include improved motor function and reduced off time, often enabling a reduction in dopaminergic medications—especially with STN targeting. Limitations include variable effects on gait freezing, speech, and balance; non-motor symptoms (sleep, constipation, mood, cognition) often require separate strategies. Risks span surgical complications (bleeding, infection), device issues (lead migration, hardware malfunction), and stimulation- or medication-related side effects (speech changes, mood shifts, balance problems). DBS requires ongoing programming sessions and eventual battery replacement; rechargeable or “

Updated March 25, 2026

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.

Medical Perspectives

Western Perspective

In Western medicine, DBS is an evidence-based surgical option for advanced PD with motor complications refractory to optimized pharmacotherapy. Electrodes in STN or GPi modulate abnormal basal ganglia-thalamo-cortical activity, improving motor symptoms and reducing dyskinesia. DBS is palliative and symptomatic—it does not modify disease progression.

Key Insights

  • Randomized trials show DBS plus best medical therapy outperforms best medical therapy alone for motor function and quality of life in advanced PD.
  • Both STN and GPi targets improve motor outcomes; STN usually permits larger medication reductions, while GPi may carry a lower risk of certain mood/cognitive effects and has strong antidyskinetic effects.
  • Earlier DBS in appropriately selected patients with emerging motor complications can improve quality of life compared with continued medical therapy alone.
  • Surgical and hardware complications occur (e.g., infection, hemorrhage, lead issues), and neuropsychiatric side effects require careful screening and follow-up.
  • DBS has limited or mixed benefit for axial symptoms (speech, balance, freezing) and does not address many non-motor symptoms; comprehensive care remains essential.

Treatments

  • DBS targeting STN or GPi
  • Best medical therapy (levodopa, adjuncts) with post-DBS optimization
  • Structured programming and follow-up
  • Rehabilitation: physical, occupational, and speech therapy
  • Management of mood, sleep, and cognitive symptoms
Evidence: Strong Evidence

Sources

  • Weaver FM et al. N Engl J Med. 2009;361:1526-1537.
  • Follett KA et al. N Engl J Med. 2010;362:2077-2091.
  • Schuepbach WM et al. N Engl J Med. 2013;368:610-622.
  • Deuschl G et al. N Engl J Med. 2006;355:896-908.
  • Okun MS. N Engl J Med. 2012;367:1529-1538.

Eastern Perspective

Traditional and integrative frameworks view PD as a chronic, systemic imbalance requiring multifaceted care. While DBS is a biomedical intervention, many Eastern approaches aim to harmonize movement, energy, and mind—supporting function, resilience, and quality of life alongside conventional treatments. In Traditional Chinese Medicine (TCM), PD-like symptoms are often conceptualized as internal wind with liver-kidney deficiency and phlegm; in Ayurveda, they align with vata imbalance. Mind–body practices and gentle movement are used to bolster balance, reduce stress reactivity, and support mobility.

Key Insights

  • Mind–body movement (e.g., tai chi, qigong, yoga) can improve balance and functional mobility and may reduce falls; evidence ranges from moderate (tai chi) to emerging (yoga/qigong).
  • Acupuncture is traditionally used for tremor and rigidity; modern evidence shows mixed and generally low-certainty effects, though some patients report symptomatic relief.
  • Ayurvedic care emphasizes calming vata (routine, gentle oil massage, meditation) and may include botanicals; any herbal use should be coordinated with clinicians due to potential interactions.
  • Integrative plans combine DBS and medications with rehabilitation, stress reduction, sleep hygiene, and nutrition to address non-motor burdens and overall well-being.

Treatments

  • Tai chi or qigong for balance and postural control
  • Yoga and mindfulness-based stress reduction
  • Acupuncture as adjunctive symptomatic therapy
  • Ayurvedic lifestyle approaches; cautious, supervised herbal use
  • Massage and breathwork to reduce rigidity and anxiety
Evidence: Moderate Evidence

Sources

  • Li F et al. N Engl J Med. 2012;366:511-519.
  • Lee MS, Ernst E. Mov Disord. 2008;23:1504-1515.
  • Cheon SM et al. Evid Based Complement Alternat Med. 2013:132701.
  • Wayne PM et al. Complement Ther Med. 2013;21:654-662.

Evidence Ratings

DBS plus best medical therapy improves motor function and quality of life more than best medical therapy alone in advanced PD.

Weaver FM et al. N Engl J Med. 2009;361:1526-1537.

Strong Evidence

STN and GPi DBS offer similar motor improvements; STN allows greater reduction of dopaminergic medications.

Follett KA et al. N Engl J Med. 2010;362:2077-2091.

Strong Evidence

Earlier DBS (in PD with recent motor complications) improves quality of life compared with continued medical therapy.

Schuepbach WM et al. N Engl J Med. 2013;368:610-622.

Strong Evidence

DBS more reliably improves tremor, rigidity, and bradykinesia than axial symptoms like speech and balance.

Okun MS. N Engl J Med. 2012;367:1529-1538.

Moderate Evidence

Serious surgical and hardware complications (e.g., infection, hemorrhage) occur in a minority of patients and require monitoring and management.

Okun MS. N Engl J Med. 2012;367:1529-1538.

Moderate Evidence

Tai chi improves balance and functional reach in PD and may reduce falls.

Li F et al. N Engl J Med. 2012;366:511-519.

Moderate Evidence

Acupuncture for PD shows mixed, low-certainty evidence for motor symptom relief.

Lee MS, Ernst E. Mov Disord. 2008;23:1504-1515.

Emerging Research

Western Medicine Perspective

From a Western clinical standpoint, deep brain stimulation is a mature, guideline-supported option for people with Parkinson’s disease who experience disabling motor complications despite optimal medication. The pathophysiology of PD involves dopaminergic neuron loss in the substantia nigra and abnormal oscillatory activity within basal ganglia–thalamo–cortical circuits. By delivering high-frequency electrical stimulation to nodes such as the subthalamic nucleus (STN) or globus pallidus internus (GPi), DBS functionally modulates these networks, improving tremor, rigidity, and bradykinesia and reducing dyskinesias. Multiple randomized trials show that combining DBS with best medical therapy yields superior motor gains and quality-of-life improvements compared to best medical therapy alone. STN and GPi are both effective; choice of target is individualized. STN DBS often enables greater reductions in dopaminergic medications, which can help diminish medication-induced dyskinesias, while GPi DBS directly suppresses dyskinesias and may present a lower risk of certain mood or cognitive side effects in some patients. Earlier use of DBS in the course of motor complications has been shown to benefit quality of life, supporting the notion that DBS need not be reserved strictly for late-stage disability. Candidacy rests on a robust response to levodopa, the presence of motor fluctuations or refractory tremor, and the absence of significant dementia or uncontrolled psychiatric disease. Preoperative evaluation includes detailed motor testing on and off medication, neuropsychological assessment, and neuroimaging. DBS is not disease-modifying; axial symptoms such as gait freezing, balance, and speech often improve less predictably and may progress over time. Non-motor symptoms typically require parallel management. Risks include surgical complications (hemorrhage, infection), hardware issues (lead migration or fracture, skin erosion), and stimulation- or medication-related side effects (speech changes, mood alterations, paresthesias). The therapy requires iterative programming sessions and future pulse-generator replacements; rechargeable systems can extend replacement intervals. Despite these burdens, many patients experience substantial reductions in off time and improved daily function. In practice, DBS is embedded within comprehensive PD care: continued medication optimization, rehabilitation (physical, occupational, and speech therapy), management of mood, sleep, and autonomic symptoms, and education for patients and care partners. Health system factors—center expertise, follow-up access, and cost—also shape outcomes. Shared decision-making helps align expectations and select candidates likely to benefit.

Eastern Medicine Perspective

Traditional and integrative perspectives approach Parkinson’s disease as a chronic imbalance affecting movement, mind, and vital energy. While DBS acts directly on neural circuitry to regulate abnormal motor rhythms, Eastern modalities aim to cultivate steadiness, flexibility, and inner calm—qualities that can complement surgical and pharmacologic care. In Traditional Chinese Medicine, PD-like tremors and stiffness may reflect internal wind combined with deficiencies or phlegm obstructing channels. Therapies such as acupuncture, tai chi, and qigong are chosen to disperse wind, nourish underlying deficiencies, and restore harmonious flow. In Ayurveda, PD corresponds to vata imbalance; care emphasizes regular routines, grounding practices, gentle oil massage, breathwork, and mindfulness to calm the nervous system. Among these approaches, the best modern evidence supports mind–body movement. Randomized trials demonstrate that tai chi improves balance, functional reach, and postural control in PD, and may reduce falls. Yoga and qigong show promise in smaller studies for flexibility, balance, and mood, although evidence is still emerging. Acupuncture is used traditionally to ease tremor and rigidity; contemporary research is mixed and generally low-certainty, with some patients reporting transient symptomatic relief. Integrative care views DBS not as a competitor but as a partner within a whole-person plan. After surgery, programming appointments, medication adjustments, and rehabilitation are complemented by gentle movement practices to reinforce balance, reduce fear of falling, and manage stress. Sleep hygiene, nutrition, and mind–body techniques may help non-motor symptoms (anxiety, fatigue). Herbal therapies require caution and collaboration with clinicians—some botanicals interact with PD medications. Cultural respect and patient preference guide choices, and ongoing dialogue ensures safety alongside individualized benefit. In this blended model, DBS addresses core motor circuitry while Eastern practices nurture resilience and quality of life across the course of PD.

Sources
  1. Weaver FM, Follett KA, Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson’s disease: a randomized controlled trial. N Engl J Med. 2009;361:1526-1537.
  2. Follett KA, Weaver FM, Stern M, et al. Pallidal vs subthalamic deep-brain stimulation for Parkinson’s disease. N Engl J Med. 2010;362:2077-2091.
  3. Schuepbach WM, Rau J, Knudsen K, et al. Neurostimulation for Parkinson’s disease with early motor complications. N Engl J Med. 2013;368:610-622.
  4. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson’s disease. N Engl J Med. 2006;355:896-908.
  5. Okun MS. Deep-brain stimulation for Parkinson’s disease. N Engl J Med. 2012;367:1529-1538.
  6. Li F, Harmer P, Fitzgerald K, et al. Tai Chi and postural stability in patients with Parkinson’s disease. N Engl J Med. 2012;366:511-519.
  7. Lee MS, Ernst E. Acupuncture in the treatment of Parkinson’s disease: a systematic review and meta-analysis. Mov Disord. 2008;23:1504-1515.

Related Topics

Topics

  • Levodopa
  • Dopamine agonists
  • Subthalamic nucleus (STN)
  • Globus pallidus internus (GPi)

Health Disclaimer

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.